Alterity stock climbs 8 percent on positive Phase 2 data for ATH434-202
ATHE Stock | USD 3.34 0.38 10.22% |
About 61% of Alterity Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Alterity Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Alterity Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Alterity Therapeutics stock news signals to limit their universe of possible portfolio assets.
Alterity |
Alterity Therapeutics stock climbed 8 percent after the company reported positive Phase 2 data from a study for its drug ATH434-202. Read more here.
Read at seekingalpha.com
Alterity Therapeutics Fundamental Analysis
We analyze Alterity Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alterity Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alterity Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Alterity Therapeutics is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Alterity Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alterity Therapeutics stock to make a market-neutral strategy. Peer analysis of Alterity Therapeutics could also be used in its relative valuation, which is a method of valuing Alterity Therapeutics by comparing valuation metrics with similar companies.
Peers
Alterity Therapeutics Related Equities
ARTL | Artelo Biosciences | 1.74 | ||||
ANEB | Anebulo Pharmaceuticals | 0.61 | ||||
SRZN | Surrozen | 1.08 | ||||
TARA | Protara Therapeutics | 1.17 | ||||
PMVP | Pmv Pharmaceuticals | 1.95 | ||||
HCWB | HCW Biologics | 2.44 | ||||
MNPR | Monopar Therapeutics | 2.78 | ||||
NBY | NovaBay Pharmaceuticals | 3.03 | ||||
ANTX | AN2 Therapeutics | 3.70 | ||||
ATXI | Avenue Therapeutics | 4.62 | ||||
ADIL | Adial Pharmaceuticals | 4.67 | ||||
RNAZ | Transcode Therapeutics | 4.99 | ||||
QNRX | Quoin Pharmaceuticals | 6.06 | ||||
RVPH | Reviva Pharmaceuticals | 6.50 | ||||
ADTX | Aditxt | 10.53 |
Complementary Tools for Alterity Stock analysis
When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |